PharmAbcine Inc. Logo

PharmAbcine Inc.

Clinical-stage biotech developing human monoclonal antibodies for various diseases.

208340 | KO

Overview

Corporate Details

ISIN(s):
KR7208340000
LEI:
Country:
South Korea
Address:
대전광역시 유성구 유성대로1689번길 70 KT대덕2연구센터 연구2동 2층, 대전광역시

Description

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-12 00:00
주주총회소집결의
Korean 9.8 KB
2024-03-12 00:00
주주총회소집공고
Korean 145.6 KB
2024-03-12 00:00
의결권대리행사권유참고서류
Korean 122.1 KB
2024-03-12 00:00
내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생
Korean 22.8 KB
2024-03-06 00:00
기타시장안내 (상장적격성 실질심사 대상 결정)
Korean 4.4 KB
2024-03-06 00:00
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
Korean 4.7 KB
2024-02-13 00:00
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)
Korean 3.2 KB
2024-01-29 00:00
임시주주총회결과
Korean 30.2 KB
2024-01-29 00:00
대표이사변경
Korean 9.7 KB
2024-01-29 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 14.1 KB
2024-01-22 00:00
기타시장안내(상장적격성 실질심사 대상결정 기한 안내)
Korean 3.0 KB
2024-01-19 00:00
기타시장안내((주)파멥신 상장적격성 실질심사관련 안내)
Korean 3.1 KB
2024-01-19 00:00
불성실공시법인지정(공시번복)
Korean 6.0 KB
2024-01-19 00:00
주권매매거래정지(상장적격성 실질심사 대상(사유발생))
Korean 4.6 KB
2024-01-16 00:00
[기재정정]최대주주변경
Korean 43.3 KB

Automate Your Workflow. Get a real-time feed of all PharmAbcine Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmAbcine Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmAbcine Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.